TD Securities initiated coverage of Kneat.com (KSIOF) with a Buy rating and C$6 price target The firm expects Kneat to continue generating “superior” organic growth in the 25%-30% range in the next two years, leveraging its leadership position for eValidation solutions in the Life Sciences industry, the analyst tells investors. The firm thinks the revenue bar “has been re-set to more realistic levels,” which may help set up future beats that could drive a rebound from a recent 52-week low, the analyst added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KSIOF:
